MDIT - Medite Cancer Diagnostics, Inc.

Other OTC - Other OTC Delayed Price. Currency in USD
Income Statement
Balance Sheet
Cash Flow

Income Statement

All numbers in thousands
Total Revenue6,8139,2389,88710,983
Cost of Revenue6,6515,6086,0847,164
Gross Profit1623,6303,8033,819
Operating Expenses
Research Development1,1881,4771,2781,243
Selling General and Administrative5,1613,6002,9472,800
Non Recurring----
Total Operating Expenses13,29310,89910,48611,377
Operating Income or Loss-6,480-1,661-599-394
Income from Continuing Operations
Total Other Income/Expenses Net-818-634-182-201
Earnings Before Interest and Taxes-6,480-1,661-599-394
Interest Expense-849-694-204-276
Income Before Tax-7,298-2,295-781-595
Income Tax Expense-487-13278104
Minority Interest----
Net Income From Continuing Ops-6,811-2,163-859-699
Non-recurring Events
Discontinued Operations----
Extraordinary Items----
Effect Of Accounting Changes----
Other Items----
Net Income
Net Income-6,811-2,163-859-699
Preferred Stock And Other Adjustments----
Net Income Applicable To Common Shares-6,902-2,254-937-808